AzTrials
AzTrials

Perinatal DepressionNCT06473935

Maternal Well-being in the Perinatal Period

An observational study of Perinatal Depression and Anxiety, run by IRCCS San Raffaele at 1 site in Italy.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The goal of this observation study is to investigate the mental health status of women experiencing their first pregnancy, with particular attention to anxiety and depression symptoms, feelings of loneliness, and the quality of defense mechanisms employed. Read more about this study

Who is it for?
Any age, women only
Conditions the study is for
Perinatal Depression, Anxiety, Loneliness
What is being tested?
Questionnaires and focus groups
How many people
134 participants
Where
1 siteItaly
Study dates
1 Jun 2024to 31 Dec 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • Women only
  • Child, Adult, Older adult

Study population: We plan to recruit a sample of at least 134 patients. This sample size allows us to meet the recommendations obtained from conducting the power analysis. The sample size calculation was performed using G*Power software (version 3.1.9.6, Faul et al., 2007).

Who may be able to join

  • Age 18 years or older
  • Adequate understanding of the Italian language
  • Willingness to participate in the study, expressed through the signing of the information sheet, consent declaration, and privacy statement
  • Women experiencing their first pregnancy
  • Women in the last trimester of gestation (28th-35th week of gestation) who will be followed for 18 months after childbirth

Who cannot join

  • Age under 18 years old
  • Women who are not able to understand the Italian language
  • Absence of the willingness to participate in the study, expressed through the signing of the information sheet, consent declaration, and privacy statement
  • Women who are not experiencing their first pregnancy
  • Women who are not in the last trimester of gestation (28th-35th week of gestation)

Trial locations and contacts

1 site in 1 country.

Valentina Di Mattei, Professor contact

0226435829

dimattei.valentina@hsr.it

Italy1 site, 1 recruiting
  • IRCCS San Raffaele

    Milan, 20132

    Valentina Di Mattei, Professor

    Recruiting

Other trials in Italy

About this study

Official title: Maternal Well-being in the Perinatal Period: a Prospective Observational Study

The goal of this observation study is to investigate the mental health status of women experiencing their first pregnancy, with particular attention to anxiety and depression symptoms, feelings of loneliness, and the quality of defense mechanisms employed.

Read the detailed description

The primary goal of this observational study si to investigate the mental health status of women experiencing their first pregnancy, with particular attention to manifestations of anxiety and depression, feelings of loneliness, and the quality of defense mechanisms employed, during the last trimester of gestation (28th-35th week of gestation) and over the course of the 18 months following the child's birth.

Furthermore, the study aims to conduct an in-depth analysis of the variables associated with the psychological adaptation of women during the perinatal period, with particular reference to the following exploratory objectives:

  • To explore the association between the investigated psychological dimensions and the quality of the bond with the child in the prenatal and postnatal periods.
  • To identify any significant differences in the variables of interest between women who conceived naturally and those who underwent assisted reproductive technology (ART).
  • To detect, through qualitative methods (semi-structured interviews and focus groups), the unmet needs of women during the perinatal period, as well as their preferences and expectations regarding the nature of desirable support interventions during this period. This would enable the construction and provision of an intervention model that closely aligns with the specific needs of this patient population.

The collected data will allow for the identification of individuals at higher risk of psychological distress and adaptation problems during the perinatal period, as well as potential impairment in the quality of the attachment bond with the child.

Being tested
Questionnaires and focus groups
Medical subject headings
Anxiety Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Questionnaires and focus groupsOther

    Participation in the research involves completing a test battery composed of self-administered questionnaires, all validated in the Italian language.

    Additionally, qualitative data will be collected through semi-structured interviews (conducted in person or online, based on individual preferences) and focus groups, both lasting between 90 and 120 minutes.

Study groups in NCT06473935
Study groupRoleWhat they receive
Women during pregnancy and postpartumWomen during the last trimester of gestation (28th-35th week of gestation) and during the 18 months following the child's birth
Receives: Other: Questionnaires and focus groups

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Depression

    Levels of perinatal depression and of pregnancy-related anxiety

    Measured: June 1, 2024 - December 31, 2025

  2. Anxiety

    Levels of state and trait anxiety

    Measured: June 1, 2024 - December 31, 2025

  3. Loneliness

    Feelings of loneliness during and after pregnancy

    Measured: June 1, 2024 - December 31, 2025

  4. Defense mechanisms

    Nature of defense mechanisms during and after pregnancy

    Measured: June 1, 2024 - December 31, 2025

Secondary outcomes (3)
  1. Attachment bond

    Quality of prenatal of attachment bond and in the postpartum period

    Measured: June 1, 2024 - December 31, 2025

  2. Women subjective experience

    Subjective experience of pregnancy and postpartum

    Measured: June 1, 2024 - December 31, 2025

  3. Unmet needs of women

    Unmet needs of women during the perinatal period

    Measured: June 1, 2024 - December 31, 2025

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Jun 2024
  2. Study start1 Jun 2024
  3. Primary completion15 Sep 2024 (estimated)
  4. Study completion31 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
134 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06473935
Sponsor's protocol ID
Benessere Materno23
Status last verified
Jun 2024
First submitted
19 Jun 2024
Last updated
25 Jun 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Perinatal Depression and Anxiety, run by IRCCS San Raffaele at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 25 Jun 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Valentina Di Mattei, Professor (0226435829, dimattei.valentina@hsr.it), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Depression (time frame: June 1, 2024 - December 31, 2025). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jun 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in